Some patients with diabetes develop a serious condition known as diabetic cardiomyopathy, which proceeds slowly and cannot be directly attributed to hypertension or other cardiovascular disorders.

Some patients with diabetes develop a serious condition known as diabetic cardiomyopathy, which is slow and cannot be directly attributed to hypertension or other cardiovascular disorders.

Some patients with diabetes develop a serious condition known as diabetic cardiomyopathy, which is slow and cannot be directly attributed to hypertension or other cardiovascular disorders.This ...

where she studied the role of antioxidant signalling in diabetic cardiomyopathy under the guidance of Dr Rebecca Ritchie and Dr Julie McMullen. She moved to London in 2013 and joined the Nature ...

Caficrestat is under clinical development by Applied Therapeutics and currently in Phase II for Coronavirus Disease 2019 (COVID-19).